Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 22, 4 Issues, 2022
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 15 - Number 2



Rationale for Development of New Oral Anticoagulants

, 15(2): 89 - 91

Muharrem Akin, Julian Widder, Ibrahim Akin, Michael Brehm and Andreas Schäfer


DOI: 10.2174/1871529X1502151209110044




Research Article








Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes

, 15(2): 148 - 161

Evgenia Verigou, Polixeni Lampropoulou, Nikoletta Smyrni, Georgia Kolliopoulou, George Sakellaropoulos, Ioannis Starakis, Panagiotis Zikos, Elena Solomou, Argiris Symeonidis and Marina Karakantza


DOI: 10.2174/1871529X15666150701105822



Editor-in-Chief

Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog